Once someone enters psychotherapy, they expect that whatever they say during a session will be protected by confidentiality, but this is not always the case.
After yielding promising results in a clinical trial, an LSD formulation aimed at treating generalized anxiety disorder has been awarded Breakthrough Therapy status by the U.S. Food and Drug Administration.